Publicaciones (50) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  3. 8.- Cannabinoides en el tratamiento de los trastornos mentales

    Usos medicinales del cannabis: ¿qué sabemos de sus propiedades curativas? (Los Libros de la Catarata), pp. 119-132

  4. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 322

  5. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance)

    International Clinical Psychopharmacology, Vol. 34, Núm. 2, pp. 89-92

  6. Aurrerapen terapeutikoak Parkinson gaixotasunean

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 36, pp. 49-64

  7. Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

    Neurotherapeutics, Vol. 16, Núm. 2, pp. 416-431

  8. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

    Neurobiology of Disease, Vol. 121, pp. 252-262

  9. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [35S]GTPγS Binding Assays

    ACS Chemical Neuroscience, Vol. 10, Núm. 11, pp. 4476-4491

  10. CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System

    Frontiers in Molecular Neuroscience, Vol. 12

  11. Cannabinoids differentially modulate cortical information transmission through the sensorimotor or medial prefrontal basal ganglia circuits

    British Journal of Pharmacology, Vol. 176, Núm. 8, pp. 1156-1169

  12. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons

    Brain Structure and Function, Vol. 224, Núm. 3, pp. 1219-1244

  13. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum

    Cells, Vol. 8, Núm. 9

  14. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

  15. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

    Translational Psychiatry, Vol. 9, Núm. 1

  16. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia

    International Review of Neurobiology (Academic Press Inc.), pp. 259-279

  17. Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model

    European Neuropsychopharmacology, Vol. 29, Núm. 5, pp. 590-600

  18. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

    Journal of Psychopharmacology, Vol. 33, Núm. 9, pp. 1132-1140

  19. Environmental enrichment shapes striatal spike-timing-dependent plasticity in vivo

    Scientific Reports, Vol. 9, Núm. 1

  20. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America